Active hexose correlated compound (AHCC) is an extract of a basidiomycete mushroom that is used as a supplement by some cancer patients undergoing chemotherapy; it is thought to enhance the therapeutic effects and reduce the side effects of some chemotherapy drugs. In the first study, AHCC given to rats was able to reduce arabinoside-induced hair loss, and 6-mercaptopurine- and methotrexate-induced liver injury. In the second study, use of AHCC reduced damage to the immune system, kidneys, and the liver when it was combined with chemotherapy drugs such as cisplatin. See

     Comments: If additional studies in humans confirm these findings, AHCC may become a useful supplement in some cancer patients undergoing chemotherapy with certain drugs.

Disclaimer: People should be taking the least amount of prescription drugs that provide adequate treatment, and to regularly monitor and review what is being taken and how much. This applies to most supplements, too. Please do not make any changes in your treatment without first discussing it with your health care provider. Statements made, or products sold through this website, have not been evaluated by the United States Food and Drug Administration. They are not intended to diagnose, treat, cure or prevent any disease.

Some articles contain affiliate links.